TwoStep Therapeutics Selected to Join JLABS
SAN CARLOS, Calif.–(BUSINESS WIRE)–TwoStep Therapeutics (“TwoStep”), a biotechnology company developing innovative, first in class, multispecific... Read more.
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT2100 for the Treatment of Cystic Fibrosis
MENLO PARK, Calif.–(BUSINESS WIRE)–ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave... Read more.
Arlington ISD Transforms Its Procurement Process with Euna Solutions Achieving Significant Cost Savings Annually
With Euna’s full-cycle procurement solution, Arlington Independent School District streamlined every stage of the procurement process, from sourcing and contracting... Read more.
Monroe Capital Supports Fusion Capital Partners’ Acquisition of Tavoron Holdings, Inc.
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC (“Monroe”) announced it acted as administrative agent and joint lead arranger on the funding of a senior... Read more.
TOLREMO Strengthens Scientific Advisory Board with Lung Cancer Expert Pasi A. Jänne
BASEL, Switzerland–(BUSINESS WIRE)–TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Pasi A. Jänne, M.D., PhD, a world renowned translational... Read more.
Red Arts Capital Names Ryan Grand as Head of Business Development to Lead Deal Origination
Ryan Grand Brings Extensive Business Development Expertise to Enhance Red Arts’ Presence in the Middle Market CHICAGO–(BUSINESS WIRE)–Red Arts Capital... Read more.
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
Presentations at the American College of Cardiology (ACC) 74th Annual Scientific Session & Expo 2025 include 10 new prespecified subgroup analyses from FINEARTS-HF,... Read more.
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
VANCOUVER, British Columbia–(BUSINESS WIRE)–SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral... Read more.
KX Emerges as Standalone Software Company to Make Temporal AI a Commercial Reality
Built for instant decisions and insights, KX’s high-performance analytical database solves the world’s toughest data challenges NEW YORK & LONDON–(BUSINESS... Read more.
Reply and AWS Announce Multi-Year Strategic Collaboration to Advance Generative AI Innovations, Helping Customers Design, Develop, and Deploy Scalable and Secure AI Applications
The new collaboration will drive the development and application of Generative AI solutions across industries, leveraging AWS services and Reply’s AI expertise.... Read more.